Quantum Cyber N.V. SEC filings QUCY
Quantum Cyber N.V. has 204 filings in SEC EDGAR's recent list, going back to Aug 3, 2021. Its latest annual report, Form ARS, was filed on Jun 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 9, 2026 | — |
| S-3 | Shelf registration | Jun 4, 2026 | — |
| S-8 | Employee stock plan registration | Feb 19, 2026 | — |
| 424B5 | Prospectus supplement | Dec 29, 2025 | — |
| 424B5 | Prospectus supplement | Dec 29, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 5, 2025 | — |
| 424B5 | Prospectus supplement | Nov 26, 2025 | — |
| 424B5 | Prospectus supplement | Oct 3, 2025 | — |
| 424B3 | Prospectus | Oct 3, 2025 | — |
| 424B3 | Prospectus | Aug 5, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Jul 30, 2025 | — |
| 424B3 | Prospectus | May 21, 2025 | — |
| F-1/A | Amendment no. 1 to form f-1 | May 14, 2025 | — |
| F-1 | Registration statement (foreign issuer) | May 14, 2025 | — |
| 424B3 | Prospectus | Dec 16, 2024 | — |
| F-1/A | Amendment no. 3 to form f-1 | Dec 11, 2024 | — |
| F-1/A | Amendment no. 2 to form f-1 | Dec 9, 2024 | — |
| F-1/A | Amendment no. 1 to form f-1 | Dec 9, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Nov 5, 2024 | — |
| 424B5 | Prospectus supplement | Nov 14, 2023 | — |
| 424B5 | Prospectus supplement | Sep 26, 2023 | — |
| S-8 | Employee stock plan registration | Jul 11, 2023 | — |
| 424B5 | Prospectus supplement | Jun 28, 2023 | — |
| 424B3 | Prospectus | Jan 10, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 30, 2022 | — |
| 424B3 | Prospectus | Jan 28, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Jan 21, 2022 | — |
| 424B3 | Prospectus | Nov 12, 2021 | — |
| 424B3 | Prospectus | Nov 12, 2021 | — |
| F-1/A | Amendment no. 2 to form f-1 | Nov 2, 2021 | — |
| FWP | Free writing prospectus | Oct 26, 2021 | — |
| F-1/A | Registration statement | Oct 26, 2021 | — |
| F-1 | Registration statement (foreign issuer) | Oct 12, 2021 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QUCY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Mainz
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1874252
- Former names
- MAINZ BIOMED N.V. (until Apr 15, 2026); Mainz Biomed B.V. (until Nov 12, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.